RA

Rosalind Advisors Portfolio holdings

AUM $283M
1-Year Est. Return 91.7%
This Quarter Est. Return
1 Year Est. Return
+91.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107M
AUM Growth
-$12.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$5.77M
2
+$5.41M
3
+$3.97M
4
OTLK icon
Outlook Therapeutics
OTLK
+$3.72M
5
UNCY icon
Unicycive Therapeutics
UNCY
+$2.59M

Top Sells

1
+$8.67M
2
+$5.78M
3
+$5.54M
4
CLRB icon
Cellectar Biosciences
CLRB
+$5.51M
5
LYRA icon
Lyra Therapeutics
LYRA
+$4.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$1.19M 1.11%
20,112
-1,040
27
$782K 0.73%
758,966
28
$777K 0.73%
+504,261
29
$660K 0.62%
200,000
30
$510K 0.48%
+200,000
31
$168K 0.16%
282
32
– –
-312,091
33
– –
0
34
– –
-196,300
35
– –
-57,400
36
– –
0
37
– –
-16,800
38
– –
-1,128,708
39
– –
-25,000
40
– –
0
41
– –
-60,000
1
2